Teva recalls lot of metronidazole tablets
Washington -- Teva Pharmaceuticals recalled one lot of metronidazole tablets, according to the U.S. Food and Drug Administration (FDA).
Washington
— Teva Pharmaceuticals recalled one lot of metronidazole tablets, according to the U.S. Food and Drug Administration (FDA).FDA says the recall was initiated because the tablets may not contain the full amount of active ingredient, which could could result in treatment failure. Metronidazole is used to treat a variety of anaerobic bacterial infections, asymptomatic trichomoniasis, amebiasis and other conditions.
The recall affects Teva’s metronidazole tablets usp, 250 mg, lot number 312566 with an expiration date of May 2012. The tablets were distributed nationwide to wholesalers and retailers in 250-count bottles.
Recalled products can be returned to the place of purchase, FDA adds.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
